The effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the nephrotoxicity in the mouse during repeated cisplatin (CDDP) treatments

Previously,we reported that specific lower dose of sodium 2,3-dimercapto-1-propanesulfonic acid (dmps) which is an antidote to heavy metal intoxication,inversely enhanced cisplatin (cddp)-induced antitumor activity to s-180 cell-bearing mouse. this activity was only weak with meso-2,3-dimercaptosuccinic acid (dmsa),however. this study investigated the effects of lower doses of dmps or dmsa on the nephrotoxicity and kinetics of cddp. kidney and blood isolated from female mice which received cddp with or without dmps or dmsa once daily for 4 days were provided for measuring levels of blood urea nitrogen (bun) and transporter proteins (oct2: organic cation transporter; mate1: multidrug and toxin extrusion) mrna,and cddp-originated platinum,and tunel staining of renal tubular cells. dmps or dmsa reduced effectively cddp-induced bun,and caused a moderate reduction of platinum in kidney. additionally,both dimercapto-compounds restored the cddp-reduced mrna levels of transporter proteins (oct2 and mate1),and apparently suppressed the cddp-induced apoptosis. these results suggest that dmps,as well as dmsa,at approximate 17-fold dose (μmol/kg) of cddp,has an enough potential to reverse the cddp nephrotoxicity,and concomitant use of dmps considering both dose and timing for administration is potentially useful for preventing nephrotoxicity and enhancing antitumor activity during cddp chemotherapy. © 2017 the authors